Ironwood Pharmaceuticals Stock News

U.S. market indexes rose on Thursday morning as investors were encouraged by several key earnings reports and Treasury yields continued to climb.

Today, we are revisiting Ironwood Pharmaceuticals for the first time since April of 2021. The company continues to live off its Lizness franchise and is putting its cash flow to good use in paying dow

Looking for U.S.-listed equities that have the characteristics listed below represents a solid starting point when screening the market for potential value opportunities, in my opinion:

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Representatives Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Of

Ironwood (IRWD) miss earnings and revenue estimates in the second quarter. Stock declines.

Ironwood (IRWD) miss earnings and revenue estimates in the second quarter. Stock declines.

Ironwood (IRWD) delivered earnings and revenue surprises of -32.26% and 2.19%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thu

To increase your chances of discovering value opportunities, you may want to look for stocks whose Graham blended multipliers are below 22.5. Created by Benjamin Graham, the father of value investing,

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD ) Q1 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Matt Roache - Director, Investor Relations Tom McCourt - Chief Executive Offi

Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates. The company maintains revenue guidance for 2022. Stock declines

Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates.

Ironwood (IRWD) delivered earnings and revenue surprises of -22.22% and 2.13%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.